Dectin-1-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy
ABSTRACT Aspergillus species cause pulmonary invasive aspergillosis resulting in nearly 100,000 deaths each year. Patients at the greatest risk of developing life-threatening aspergillosis have weakened immune systems and/or various lung disorders. Patients are treated with antifungals such as ampho...
Main Authors: | Suresh Ambati, Aileen R. Ferarro, S. Earl Kang, Jianfeng Lin, Xiaorong Lin, Michelle Momany, Zachary A. Lewis, Richard B. Meagher |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2019-02-01
|
Series: | mSphere |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/mSphere.00025-19 |
Similar Items
-
Dectin-2-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy
by: Suresh Ambati, et al.
Published: (2019-10-01) -
Erratum for Ambati et al., “Dectin-1-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy”
by: Suresh Ambati, et al.
Published: (2019-04-01) -
Azole Resistance in Aspergillus fumigatus: A Consequence of Antifungal Use in Agriculture?
by: Sarah Berger, et al.
Published: (2017-06-01) -
Therapeutic potential of Calotropis gigantea extract against invasive pulmonary aspergillosis: In vitro and in vivo study
by: Enas M Ali, et al.
Published: (2022-01-01) -
Management of cerebral azole-resistant Aspergillus fumigatus infection: A role for intraventricular liposomal-amphotericin B
by: A.F.A.D. Schauwvlieghe, et al.
Published: (2020-09-01)